QTXB — Quantrx Biomedical Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $1.58m
Annual cashflow statement for Quantrx Biomedical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 0.869 | -0.737 | -0.622 | -0.253 | -0.26 |
| Depreciation | |||||
| Non-Cash Items | -1.28 | 0.269 | 0.222 | -0.025 | 0 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.249 | 0.21 | 0.208 | 0.202 | 0.211 |
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -0.151 | -0.258 | -0.192 | -0.075 | -0.049 |
| Other Investing Cash Flow Items | 0.497 | 0.201 | 0 | — | — |
| Sale of Intangible Assets | |||||
| Cash from Investing Activities | 0.497 | 0.201 | 0 | — | — |
| Financing Cash Flow Items | — | — | — | 0 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.113 | -0.081 | 0 | 0 | 0 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.459 | -0.138 | -0.192 | -0.075 | -0.049 |